Pharmaceutical companies

Dwindling antibiotics undermine fight against drug-resistant infections, WHO warns

In this illustration, a pill is surrounded by antibodies
Illustration: Sarah Grillo/Axios

Shrinking investment and a lack of innovation in the development of new antibiotics is "undermining efforts to combat drug-resistant infections," the World Health Organization warned on Friday, citing two of its new reports.

Why it matters: "Without government intervention, the United Nations estimates that resistant infections could kill 10 million people annually by 2050 and prompt an economic slowdown to rival the global financial crisis of 2008," the New York Times reports.

Private insurance is health care's pot of gold

Illustration of a golden stethoscope.
Illustration: Aïda Amer/Axios

Private health insurance is a conduit for exploding health care spending, and there's no end in sight.

The big picture: Most politicians defend this status quo, even though prices are soaring. And as the industry's top executives and lobbyists gathered this week in San Francisco, some nodded to concerns over affordability — but then went on to tell investors how they plan to keep the money flowing.